Lirafit™

Glenmark Makes History: Unveils India’s First Biosimilar of Liraglutide, a Game-Changer in Diabetes Treatment

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic drug, Liraglutide, for the…